s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
D
Exempt (Private) Offering
Filed
Thursday, November 14, 2024
Accession number
0001493152-24-045321
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header